Belgium· BE-AMP-SAM158724-00
Act-HIB 10 µg/0.5 ml
A haemophilus influenzae b, gereinigtes antigen konjugiert product containing conjugate of haemophilus influenzae type b capsular polysaccharide and tetanus toxoid, registered in Belgium by Sanofi Winthrop Industrie. The same ATC class is registered in 8 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Haemophilus influenzae b, gereinigtes antigen konjugiert is registered in 8 of 19 countries.
Countries holding a registration under ATC J07AG01 (haemophilus influenzae b, gereinigtes antigen konjugiert), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Haemophilus influenzae b, gereinigtes antigen konjugiert · ATC J07AG01
8 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Conjugate of Haemophilus influenzae type b capsular polysaccharide and Tetanus toxoid
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Belgium (BE)
- ATC code
- J07AG01
- ATC class
- Haemophilus influenzae B, gereinigtes Antigen konjugiert
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0320879
- be_apb0739995
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AG01
Haemophilus influenzae b, gereinigtes antigen konjugiert, as other registers publish it.
- FinlandAct-HibSanofi Winthrop Industrie
- NorwayAct-HibSanofi Winthrop Industrie
- PolandAct-HiBSanofi Winthrop Industrie
- NorwayAct-HIBSanofi Pasteur
- CanadaACT-HIBSANOFI PASTEUR LIMITED
- NetherlandsAct-Hib, 10 microgram/0,5 ml poeder en oplosmiddel voor oplossing voor injectieSanofi Winthrop Industrie
- FinlandHiberixGlaxoSmithKline Biologicals SA
- SwitzerlandHiberix
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/31ce9066-268e-4e2b-8300-4c55d9f2beee GET /v1/drugs/31ce9066-268e-4e2b-8300-4c55d9f2beee?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Act-HIB 10 µg/0.5 ml",
"name_fr": "Act-HIB 10 µg/0.5 ml",
"name_nl": "Act-HIB 10 µg/0.5 ml",
"amp_code": "SAM158724-00",
"strengths": null,
"pack_count": 2,
"substances": [
"Conjugate of Haemophilus influenzae type b capsular polysaccharide and Tetanus toxoid",
"Sodium Chloride",
"Sucrose"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Haemophilus Influenzae B, Purified Antigen Conjugated",
"authorisation_numbers": [
"BE158724"
]
}See everything about haemophilus influenzae b, gereinigtes antigen konjugiert.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.